Advances in the field of nanooncology

BMC Medicine

Volumn 8, Issue , 2010, Pages 83-

  Jain, KK ^a  

^a JAIN PHARMABIOTECH   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; ASPARAGINASE MACROGOL; BIOLOGICAL MARKER; CAMPTOTHECIN; CISPLATIN; COPOLYMER; CPX 1; CYCLODEXTRIN; CYT 6091; DAUNORUBICIN; DENILEUKIN DIFTITOX; DOXORUBICIN; EPIDERMAL GROWTH FACTOR RECEPTOR ANTIBODY; FLOXURIDINE; GOLD NANOPARTICLE; GOSERELIN; IBRITUMOMAB TIUXETAN; IRINOTECAN; IT 101; LE SN 38; LIPOSOME; MAGNETIC NANOPARTICLE; MCC 465; MONOCLONAL ANTIBODY; MYOSET; NC 6004; NK 105; NK 911; PACLITAXEL; PK 1; QUANTUM DOT; SP 1049C; SUPERPARAMAGNETIC IRON OXIDE; TOSITUMOMAB I 131; TUBULYSIN A; ULTRASMALL SUPERPARAMAGNETIC IRON OXIDE; UNCLASSIFIED DRUG; ZINOSTATIN; ZINOSTATIN MALEIC ACID STYRENE COPOLYMER;

ACOUSTICS; BIOSENSOR; CANCER DIAGNOSIS; CLINICAL TRIAL (TOPIC); DRUG DELIVERY SYSTEM; HUMAN; MICELLE; NANOBIOTECHNOLOGY; NANOMEDICINE; NANOONCOLOGY; NUCLEAR MAGNETIC RESONANCE IMAGING; REVIEW; TUMOR CELL;

EID: 78649974950     PISSN: None     EISSN: 17417015     Source Type: Journal    
DOI: 10.1186/1741-7015-8-83     Document Type: Review

References (44)

1. Jain KK. A Handbook of Nanomedicine 2008, Totowa, NJ: Humana/Springer.
2. Jain KK. Applications of nanobiotechnology in clinical diagnostics. Clin Chem 2007, 53:2002-2009. 10.1373/clinchem.2007.090795, 17890442.
3. El-Sayed IH, Huang X, El-Sayed M. Selective laser photo-thermal therapy of epithelial carcinoma using anti-EGFR antibody conjugated gold nanoparticles. Cancer Lett 2006, 239:129-135. 10.1016/j.canlet.2005.07.035, 16198049.
4. Choi JS, Jun YW, Yeon SI, Kim HC, Shin JS, Cheon J. Biocompatible heterostructured nanoparticles for multimodal biological detection. J Am Chem Soc 2006, 128:15982-15983. 10.1021/ja066547g, 17165720.
5. Bailey VJ, Easwaran H, Zhang Y, Griffiths E, Belinsky SA, Herman JG, Baylin SB, Carraway HE, Wang TH. MS-qFRET: a quantum dot-based method for analysis of DNA methylation. Genome Res 2009, 19:1455-1461. 10.1101/gr.088831.108, 2720185, 19443857.
6. Jain KK. A Handbook of Biomarkers 2010, New York: Springer.
7. Gaster RS, Hall DA, Nielsen CH, Osterfeld SJ, Yu H, Mach KE, Wilson RJ, Murmann B, Liao JC, Gambhir SS, Wang SX. Matrix-insensitive protein assays push the limits of biosensors in medicine. Nat Med 2009, 15:1327-1332. 10.1038/nm.2032, 19820717.
8. Galanzha EI, Shashkov EV, Kelly T, Kim JW, Yang L, Zharov VP. In vivo magnetic enrichment and multiplex photoacoustic detection of circulating tumour cells. Nat Nanotechnol 2009, 4:855-860. 10.1038/nnano.2009.333, 19915570.
9. Ross RW, Zietman AL, Xie W, Coen JJ, Dahl DM, Shipley WU, Kaufman DS, Islam T, Guimaraes AR, Weissleder R, Harisinghani M. Lymphotropic nanoparticle-enhanced magnetic resonance imaging (LNMRI) identifies occult lymph node metastases in prostate cancer patients prior to salvage radiation therapy. Clin Imaging 2009, 33:301-305. 10.1016/j.clinimag.2009.01.013, 19559353.
10. Kosaka N, McCann TE, Mitsunaga M, Choyke PL, Kobayashi H. Real-time optical imaging using quantum dot and related nanocrystals. Nanomedicine (Lond) 2010, 5:765-776. 10.2217/nnm.10.49, 20662647.
11. Batist G, Gelmon KA, Chi KN, Miller WH, Chia SK, Mayer LD, Swenson CE, Janoff AS, Louie AC. Safety, pharmacokinetics, and efficacy of CPX-1 liposome injection in patients with advanced solid tumors. Clin Cancer Res 2009, 15:692-700. 10.1158/1078-0432.CCR-08-0515, 19147776.
12. Matsumura Y, Gotoh M, Muro K, Yamada Y, Shirao K, Shimada Y, Okuwa M, Matsumoto S, Miyata Y, Ohkura H, Chin K, Baba S, Yamao T, Kannami A, Takamatsu Y, Ito K, Takahashi K. Phase I and pharmacokinetic study of MCC-465, a doxorubicin (DXR) encapsulated in PEG immunoliposome, in patients with metastatic stomach cancer. Ann Oncol 2004, 15:517-525. 10.1093/annonc/mdh092, 14998859.
13. Matsumura Y. Poly (amino acid) micelle nanocarriers in preclinical and clinical studies. Adv Drug Deliv Rev 2008, 60:899-914. 10.1016/j.addr.2007.11.010, 18406004.
14. Seymour LW, Ferry DR, Kerr DJ, Rea D, Whitlock M, Poyner R, Boivin C, Hesslewood S, Twelves C, Blackie R, Schatzlein A, Jodrell D, Bissett D, Calvert H, Lind M, Robbins A, Burtles S, Duncan R, Cassidy J. Phase II studies of polymer-doxorubicin (PK1, FCE28068) in the treatment of breast, lung and colorectal cancer. Int J Oncol 2009, 34:1629-1636. 10.3892/ijo_00000293, 19424581.
15. Valle JW, Armstrong A, Newman C, Alakhov V, Pietrzynski G, Brewer J, Campbell S, Corrie P, Rowinsky EK, Ranson M. A phase 2 study of SP1049C, doxorubicin in P-glycoprotein-targeting pluronics, in patients with advanced adenocarcinoma of the esophagus and gastroesophageal junction. Invest New Drugs 2010,
16. Yeh TK, Lu Z, Wientjes MG, Au JL. Formulating paclitaxel in nanoparticles alters its disposition. Pharm Res 2005, 22:867-874. 10.1007/s11095-005-4581-4, 15948030.
17. Gibson JD, Khanal B, Zubarev E. Paclitaxel-functionalized gold nanoparticles. J Am Chem Soc 2007, 129:11653-11661. 10.1021/ja075181k, 17718495.
18. Gradishar WJ, Tjulandin S, Davidson N, Shaw H, Desai N, Bhar P, Hawkins M, O'Shaughnessy J. Superior efficacy of albumin-bound paclitaxel, ABI-007, compared with polyethylated castor oil-based paclitaxel in women with metastatic breast cancer: results of a phase III trial. J Clin Oncol 2005, 23:7794-7803. 10.1200/JCO.2005.04.937, 16172456.
19. Wagner E. Programmed drug delivery: nanosystems for tumor targeting. Expert Opin Biol Ther 2007, 7:587-593. 10.1517/14712598.7.5.587, 17477797.
20. Torchilin VP. Passive and active drug targeting: drug delivery to tumors as an example. Handb Exp Pharmacol 2010, 197:3-53. full_text, 20217525.
21. Ruoslahti E, Bhatia SN, Sailor MJ. Targeting of drugs and nanoparticles to tumors. J Cell Biol 2010, 188:759-768. 10.1083/jcb.200910104, 2845077, 20231381.
22. Kumar M, Yigit M, Dai G, Moore A, Medarova Z. Image-guided breast tumor therapy using a siRNA nanodrug. Cancer Res 2010, 70:7553-7561. 10.1158/0008-5472.CAN-10-2070, 20702603.
23. Yen Y, Synold T, Schluep T, Hwang J, Oliver J, Davis ME. First-in-human phase I trial of a cyclodextrin-containing polymer-camptothecin nanoparticle in patients with solid tumors. J Clin Oncol 2007, 25(18S):14078.
24. Rapoport N, Gao Z, Kennedy A. Multifunctional nanoparticles for combining ultrasonic tumor imaging and targeted chemotherapy. J Natl Cancer Inst 2007, 99:1095-1106. 10.1093/jnci/djm043, 17623798.
25. Cardinal J, Klune JR, Chory E, Jeyabalan G, Kanzius JS, Nalesnik M, Geller DA. Noninvasive radiofrequency ablation of cancer targeted by gold nanoparticles. Surgery 2008, 144:125-132. 10.1016/j.surg.2008.03.036, 2596609, 18656617.
26. Shenoi MM, Anderson J, Bischof JC. Nanoparticle enhanced thermal therapies. Conf Proc IEEE Eng Med Biol Soc 2009 2009, 1979-1982.
27. Huff TB, Tong L, Zhao Y, Hansen MN, Cheng JX, Wei A. Hyperthermic effects of gold nanorods on tumor cells. Nanomedicine (Lond) 2007, 2:125-132. 10.2217/17435889.2.1.125, 2597406, 17716198.
28. Bardhan R, Chen W, Perez-Torres C, Bartels M, Huschka RM, Zhao LL, Morosan E, Pautler RG, Joshi A, Halas NJ. Nanoshells with targeted simultaneous enhancement of magnetic and optical imaging and photothermal therapeutic response. Adv Functional Mater 19:3901-3909.
29. Hilger I, Hergt R, Kaiser WA. Use of magnetic nanoparticle heating in the treatment of breast cancer. IEE Proc Nanobiotechnol 2005, 152:33-39. 10.1049/ip-nbt:20055018, 16441156.
30. Ito A, Kuga Y, Honda H, Kikkawa H, Horiuchi A, Watanabe Y, Kobayashi T. Magnetite nanoparticle-loaded anti-HER2 immunoliposomes for combination of antibody therapy with hyperthermia. Cancer Lett 2004, 212:167-175. 10.1016/j.canlet.2004.03.038, 15279897.
31. Richter H, Kettering M, Wiekhorst F, Steinhoff U, Hilger I, Trahms L. Magnetorelaxometry for localization and quantification of magnetic nanoparticles for thermal ablation studies. Phys Med Biol 2010, 55:623-633. 10.1088/0031-9155/55/3/005, 20071755.
32. Krishnan S, Diagaradjane P, Cho SH. Nanoparticle-mediated thermal therapy: evolving strategies for prostate cancer therapy. Int J Hyperthermia 2010, 26:775-789. 10.3109/02656736.2010.485593, 20858069.
33. Chakravarty P, Marches R, Zimmerman NS, Swafford AD, Bajaj P, Musselman IH, Pantano P, Draper RK, Vitetta ES. Thermal ablation of tumor cells with antibody-functionalized single-walled carbon nanotubes. Proc Natl Acad Sci USA 2008, 105:8697-8702. 10.1073/pnas.0803557105, 2438394, 18559847.
34. Cinteza LO, Ohulchanskyy TY, Sahoo Y, Bergey EJ, Pandey RK, Prasad PN. Diacyllipid micelle-based nanocarrier for magnetically guided delivery of drugs in photodynamic therapy. Mol Pharm 2006, 3:415-423. 10.1021/mp060015p, 16889435.
35. Ohulchanskyy TY, Roy I, Goswami LN, Chen Y, Bergey EJ, Pandey RK, Oseroff AR, Prasad PN. Organically modified silica nanoparticles with covalently incorporated photosensitizer for photodynamic therapy of cancer. Nano Lett 2007, 7:2835-2842. 10.1021/nl0714637, 17718587.
36. Puri A, Kramer-Marek G, Campbell-Massa R, Yavlovich A, Tele SC, Lee SB, Clogston JD, Patri AK, Blumenthal R, Capala J. HER2-specific affibody-conjugated thermosensitive liposomes (Affisomes) for improved delivery of anticancer agents. J Liposome Res 2008, 18:293-307. 10.1080/08982100802457377, 18937120.
37. Jain KK. Textbook of Personalized Medicine 2009, New York: Springer.
38. Jain KK. Role of nanobiotechnology in developing personalized medicine for cancer. Technol Cancer Res Treat 2005, 4:407-416.
39. Sakamoto J, Annapragada A, Decuzzi P, Ferrari M. Antibiological barrier nanovector technology for cancer applications. Expert Opin Drug Deliv 2007, 4:359-369. 10.1517/17425247.4.4.359, 17683250.
40. Baker JR. Dendrimer-based nanoparticles for cancer therapy. Hematology Am Soc Hematol Educ Program 2009, 708-719.
41. Santra S, Kaittanis C, Grimm J, Perez JM. Drug/dye-loaded, multifunctional iron oxide nanoparticles for combined targeted cancer therapy and dual optical/magnetic resonance imaging. Small 2009, 5:1862-1868. 10.1002/smll.200900389, 19384879.
42. Nie S, Xing Y, Kim GJ, Simons JW. Nanotechnology applications in cancer. Annu Rev Biomed Eng 2007, 9:257-288. 10.1146/annurev.bioeng.9.060906.152025, 17439359.
43. Jain KK. Nanobiotechnology: Technologies, Markets and Companies 2010, Basel, Switzerland: Jain PharmaBiotech Publications.
44. Jain KK. Recent advances in nanooncology. Technol Cancer Res Treat 2008, 7:1-13.